Colorectal Cancer Diagnostics Market
Medical Device

Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Mayur SComments Off on Colorectal Cancer Diagnostics Market Scope 2028 – Navigating the Competitive World

Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.

Medtronic Plc and Boston Scientific Corporation – Notable Market Players in Colorectal Cancer Diagnostics Market

Key driving factors include the factors driving the colorectal cancer diagnostics market growth are increasing prevalence of colorectal cancer and launches of new products. However, the low accuracy of screening based on fecal immunochemical tests (FITs)hinders the colorectal cancer diagnostics market growth. 

The colorectal cancer diagnostics market is majorly comprised of top players involving Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co., Ltd. among others.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the colorectal cancer diagnostics market:       

Year

News

March 2023

Sengkang General Hospital collaborate with Medtronic promote AI-assisted colonoscopies.
The two organizations have signed a memorandum of understanding to promote AI-assisted colonoscopy
for colorectal cancer screening.

August 2021

Illumina Acquired GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test.
GRAIL’s Galleri blood test detects 50 different cancers before they are symptomatic. Illumina’s acquisition of
GRAIL will accelerate access and adoption of this life-saving test worldwide.

January 2020

Illumina, Roche Launched NGS-Based Cancer Diagnostics Partnership. Illumina and Roche have
signed a 15-year, non-exclusive collaboration agreement designed to realize next-generation
sequencing’s potential to transform cancer risk prediction, detection, diagnosis, treatment, and monitoring.

April 2020

Clinical Genomics Expands Strategic Relationship with Quest Diagnostics for Innovative First-Line Colorectal Cancer Screening Blood Test.
The alliance also expands the company’s commercialization rights for hte Trident Program and COLVERA for CRC monitoring outside the US,
Mexico, UK, and India.

 

Mayur S
https://www.theinsightpartners.com/

Related Articles

Breast Pump Market
Medical Device

$5,778.97 Million, Breast Pump Market is Surging with 10.7% of CAGR by 2028

The Insight Partners

  Breast pump is an emerging market consisting of the good and countable number of players, having considerable revenue in the market. Most of the companies operating in the global breast pump market offer breast pumps to the mothers who need to feed their babies. Breast pump is most popular device in working women or […]
Medical Device

Musculoskeletal Diseases Treatment Market Is Expected to Reach US$ 5,730.8 MN In 2025 From US$ 3,837.9 In 2017

The Insight Partners

Rising Prevalence of Musculoskeletal Disorders is expected to enhance the Musculoskeletal Diseases Treatment Market from 2018 to 2025. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025. Rising prevalence of musculoskeletal disorders is expected to drive the growth of the market. However, high costs of diagnostic systems in […]

Glycomics Market
Medical Device

Whole Slide Imaging Market  is estimated to grow at a CAGR of 18.2% from 2022 to 2028.  

The Insight Partners

Olympus Corporation and Danaher (Leica Biosystems) – Notable Market Players in Whole Slide Imaging Market       Whole slide imaging technology deals with the acquisition of high-speed, high-resolution slide images for pathology workflow. The technology is also known as virtual pathology and plays major role in the digital pathology. Whole slide imaging is responsible for image […]